Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nevi and Melanomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02285413
What this trial is testing

Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients

Who this might be right for
Melanoma
Radboud University Medical Center 54
Large-scale testing (Phase 3)Looking for participantsNCT07015190
What this trial is testing

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Who this might be right for
Uveal Melanoma
IDEAYA Biosciences 520
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05893654
What this trial is testing

Melphalan Chemoreduction for Ocular Melanoma

Who this might be right for
Uveal Melanoma
Hospital das Clínicas de Ribeirão Preto 10
Early research (Phase 1)Ended earlyNCT07121829
What this trial is testing

Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors

Who this might be right for
MelanomaSolid TumorPilocytic Astrocytoma+7 more
Day One Biopharmaceuticals, Inc. 44
Very early researchStudy completedNCT00743353
What this trial is testing

Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5

Who this might be right for
SarcomaMelanomaLung Cancer+2 more
Siemens Molecular Imaging 16
Not applicableUnknownNCT03797053
What this trial is testing

Ex Vivo Expansion of Circulating Tumor Cells as a Model for Cancer Predictive Pharmacology

Who this might be right for
MelanomaCirculating Tumor Cell
Assistance Publique - Hôpitaux de Paris 450
Early research (Phase 1)Ended earlyNCT05061537
What this trial is testing

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

Who this might be right for
Renal Cell CancerMelanomaNon-Small-Cell Lung Cancer+7 more
Pfizer 13
Early research (Phase 1)Study completedNCT01625351
What this trial is testing

CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

Who this might be right for
Ewing SarcomaGastrointestinal TumorGerm Cell Tumor+10 more
St. Jude Children's Research Hospital 23
Testing effectiveness (Phase 2)Ended earlyNCT05169437
What this trial is testing

Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

Who this might be right for
Solid TumorBreast TumorColon Tumor, Malignant+9 more
Tempus AI 22
Testing effectiveness (Phase 2)Study completedNCT00089063
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+6 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00405587
What this trial is testing

Safety Study of PLX4032 in Patients With Solid Tumors

Who this might be right for
Malignant MelanomaColorectal Carcinoma
Plexxikon 109
Not applicableNot Yet RecruitingNCT07653087
What this trial is testing

Evaluating a Decision Aid for Sentinel Lymph Node Biopsy in Intermediate-Risk Melanoma

Who this might be right for
Sentinel Lymph Node Biopsy (SLNB)Melanoma (Skin Cancer)
University of Virginia 66
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06848088
What this trial is testing

Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment

Who this might be right for
Melanoma
Regeneron Pharmaceuticals 48
Not applicableStudy completedNCT01898403
What this trial is testing

Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma

Who this might be right for
Recurrent Melanoma
Stanford University 50
Not applicableStudy completedNCT05954546
What this trial is testing

Compare How Effective is Encorafenib Plus Binimetinib in Real-world and Clinical Trial Settings

Who this might be right for
Metastatic Melanoma
Pfizer 275
Testing effectiveness (Phase 2)Study completedNCT07671495
What this trial is testing

Adjuvant Therapy of Skin Melanoma With Alpha Interferon and Naderin

Who this might be right for
Melanoma Stage IMelanoma Stage IIIMelanoma Stage II+1 more
MIPO Clinic 278
Not applicableStudy completedNCT05421988
What this trial is testing

Effectiveness of Group and Individual Training in EFT for Patients in Remission From Melanoma

Who this might be right for
Melanoma (Skin)
Soul Medicine Institute 56
Testing effectiveness (Phase 2)Looking for participantsNCT07057596
What this trial is testing

Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma

Who this might be right for
Mestastatic Uveal Melanoma
Grupo Español Multidisciplinar de Melanoma 19
Large-scale testing (Phase 3)Active Not RecruitingNCT00003641
What this trial is testing

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

Who this might be right for
Melanoma (Skin)
ECOG-ACRIN Cancer Research Group 1,150
Early research (Phase 1)Study completedNCT00112242
What this trial is testing

Immunotherapy of Stage III/IV Melanoma Patients

Who this might be right for
Melanoma
Centre Hospitalier Universitaire Vaudois 39
Next Page